Sally E. Wenzel
Impact in
- Physiology top 0.01%
- Asthma and respiratory diseases
- Immunology and Allergy top 0.02%
- Allergic Rhinitis and Sensitization
Papers in
- Physiology 267
- Asthma and respiratory diseases 265
-
- Respiratory and Cough-Related Research 49
- Inhalation and Respiratory Drug Delivery 37
- Chronic Obstructive Pulmonary Disease (COPD) Research 26
- Neonatal Respiratory Health Research 15
- Co-authors
- William W. Busse (51 shared papers)John B. Trudeau (44 shared papers)Eugene R. Bleecker (64 shared papers)Mario Castro (59 shared papers)Silvana Balzar (24 shared papers)Jean Bousquet (7 shared papers)Hong Wei Chu (11 shared papers)Serpil C. Erzurum (44 shared papers)
- Journals
- Journal of Allergy and Clinical Immunology (80 papers)American Journal of Respiratory and Critical Care Medicine (38 papers)CHEST Journal (19 papers)Clinical & Experimental Allergy (10 papers)Journal of Asthma (7 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Sally E. Wenzel
355 papers receiving 34.2k citations
Sally E. Wenzel's Hit Papers
Peers
Comparison fields: 5 of 180
- Physiology 23.3k
- Immunology and Allergy 4.2k
- Pulmonary and Respiratory Medicine 12.4k
- Immunology 7.2k
- Emergency Medical Services 1.8k
Countries citing papers authored by Sally E. Wenzel
This map shows the geographic impact of Sally E. Wenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally E. Wenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally E. Wenzel more than expected).
Fields of papers citing papers by Sally E. Wenzel
This network shows the impact of papers produced by Sally E. Wenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally E. Wenzel. The network helps show where Sally E. Wenzel may publish in the future.
Co-authors
The 25 scholars most cited alongside Sally E. Wenzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 367 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global strategy for asthma management and prevention: GINA executive summary Hit paper breakdown → | 2007 | 2407 |
| 2 | Asthma phenotypes: the evolution from clinical to molecular approaches Hit paper breakdown → | 2012 | 1729 |
| 3 | Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma Hit paper breakdown → | 2014 | 1200 |
| 4 | Dupilumab in Persistent Asthma with Elevated Eosinophil Levels Hit paper breakdown → | 2013 | 958 |
| 5 | Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics Hit paper breakdown → | 1999 | 918 |
| 6 | Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome Hit paper breakdown → | 2011 | 823 |
| 7 | Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma Hit paper breakdown → | 2017 | 744 |
| 8 | Asthma: defining of the persistent adult phenotypes Hit paper breakdown → | 2006 | 726 |
| 9 | Exploring the Effects of Omalizumab in Allergic Asthma Hit paper breakdown → | 2013 | 678 |
| 10 | Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial Hit paper breakdown → | 2016 | 641 |
| 11 | Bronchoscopic Evaluation of Severe Asthma Hit paper breakdown → | 1997 | 598 |
| 12 | A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma Hit paper breakdown → | 2007 | 553 |
| 13 | Asthma Hit paper breakdown → | 2015 | 467 |
| 14 | 2007 | 455 | |
| 15 | Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis Hit paper breakdown → | 2013 | 449 |
| 16 | Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study Hit paper breakdown → | 2015 | 427 |
| 17 | 2004 | 424 | |
| 18 | 2016 | 377 | |
| 19 | 2013 | 374 | |
| 20 | 2009 | 372 |
About Sally E. Wenzel
Sally E. Wenzel is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Molecular Biology, having authored 367 papers that have together received 35.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (265 papers), Respiratory and Cough-Related Research (49 papers), IL-33, ST2, and ILC Pathways (42 papers), Inhalation and Respiratory Drug Delivery (37 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers), Eosinophilic Esophagitis (25 papers), Allergic Rhinitis and Sensitization (24 papers) and Neonatal Respiratory Health Research (15 papers). The work is most often cited by research in Physiology (23.3k citations), Immunology and Allergy (4.2k citations), Pulmonary and Respiratory Medicine (12.4k citations), Immunology (7.2k citations) and Emergency Medical Services (1.8k citations). Sally E. Wenzel has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include William W. Busse, John B. Trudeau, Eugene R. Bleecker, Mario Castro, Silvana Balzar, Jean Bousquet, Hong Wei Chu, Serpil C. Erzurum, Jay Y. Westcott and Merritt L. Fajt. Their work appears in journals such as Journal of Allergy and Clinical Immunology, American Journal of Respiratory and Critical Care Medicine, CHEST Journal, Clinical & Experimental Allergy and Journal of Asthma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.